Ken Krause
Analyst · Stifel. Please go ahead
Thanks, Nish. And good morning, everyone. I'll start the discussion with financial highlights centered around growth, profitability and our balance sheet before providing more detail on the fourth quarter. We had a strong finish. The acquisitions we made earlier this year, combined with strength in industrial PPE, notably head protection, portable gas detection and fall protection drove revenues to a quarterly record. While orders were strong in fixed gas and flame detection, SCBA and turnout gear, supply chain and labor constraints had an impact on deliveries and drove our quarterly book-to-bill ratio above one times and backlog to record levels. It was good to see the strong finish in margins. Despite the ongoing inflationary and supply chain challenges, we continue to see a very healthy level of gross margins, a strong improvement in adjusted operating margin and a return to over 40% incremental margins. This performance speaks to our ability to realize price improvement, combined with our ongoing focus on improving productivity. And we took the opportunity to continue to invest in the business to drive long-term profitable growth and enhance our market positions throughout 2021. We invested over $400 million for the year in strategic acquisitions, technology partnerships and capital expenditures and returned nearly $70 million to shareholders through dividends. Our balance sheet remains strong with net leverage of 1.6 times at year-end. We are positioned well to maintain our balanced approach to capital allocation. Before reviewing the details of the quarter, I want to summarize the non-cash charge, our subsidiary, MSA LLC took related to cumulative trauma product liability claims in the quarter. Consistent with prior years, in the fourth quarter, we conducted the annual review process to determine MSA LLC's cumulative trauma product liability claims reserve. Based on that review, MSA LLC's product liability reserve increased by $182 million, which reflects the estimated liability through 2074. Net of insurance recoveries, the pretax charge was $160 million. It is important to note that non-cash charges related to products sold many years ago and are no longer offered for sale. At the same time, MSA LLC continues to defend and resolve the claims that are currently pending. Now let's take a closer look at the financial results in the quarter. I'll start with a focus on revenue. We achieved record quarterly revenue of $410 million, an increase of 6% over the prior year. Acquisition-related revenues and strong growth in industrial PPE were weighed down by lower sales of pandemic-related respiratory products. While SCBA and FGFD were down organically in the quarter, healthy orders and ongoing supply chain challenges drove backlog up in these areas. From a geographic perspective, revenue in our Americas segment was up 4% overall and down 2% on an organic constant currency basis driven by lower sales of non-core products. Core product revenue was up 2% on an organic constant currency basis. In our International segment, revenue was up 9% overall and down 1% on an organic constant currency basis. The healthy demand trends we saw in the quarter continued throughout the fourth quarter or continued throughout the first quarter. Order activity was strong, finishing ahead of the pre-pandemic levels of 2019 and has remained healthy to start 2022. We finished the quarter with a book-to-bill well above one times. Our teams executed well in light of the challenging environment, but we continue to face shortages in electronic components impacting our ability to ship certain products and the challenges are intensifying to start the year. From what we're seeing in the market, we expect supply chain challenges to persist well into this year and don't expect meaningful improvement in the first half of 2022. Turning to profitability and earnings. Gross profit totaled $178 million or 43.4% of sales in the quarter compared to $162 million or 41.8% on sales in the prior year. Gross profit margin was negatively impacted by 70 basis points for purchase price amortization related to the Bacharach and Bristol acquisitions we made in 2021. Excluding this, gross profit margin was a healthy 44.1% in the quarter, up 230 basis points compared to a year ago. It is important to note that the change to FIFO did not have an impact on the margin comparison as all periods have been restated. We implemented several price increases in 2021 to offset inflation. We had a price increase take effect in our Americas segment during the quarter and one went into effect on January 1 in our International segment. While we continue to see inflation at varying levels in the regions we operate, we are taking the necessary pricing actions and remain focused on taking additional actions to mitigate the impact of inflation on our margins. SG&A expense in the quarter was $87 million or 21.1% of revenue, up $10 million from the prior year. This was driven primarily by $7 million of increased costs from acquired companies, $3 million in variable compensation and $3 million in discretionary costs, which were offset by about $2 million in cost savings. I'm pleased to see the second half SG&A expense come in lower than the 23.5% we guided to in September. We continue to invest in restructuring programs to enhance operational productivity and margin performance across our business, and ultimately drive improved incremental margin leverage, which we saw come through this quarter. Our quarterly adjusted operating margin was 19.5%, an increase of 150 basis points from a year ago. We saw healthy incremental margins in quarter over - in the quarter of over 40%. Looking at our segment performance. Americas adjusted operating margin was 23.9%, up 200 basis points year-over-year, while International's adjusted operating margin was very strong at 19.9%, up 230 basis points year-over-year. When I think back the commitments we made at Investor Day in late 2019 related to international, the team has delivered on the profitability expansion goals with a focus on pricing, productivity improvements and complexity reduction. I'm also pleased to see that gross margin was up year-over-year in both of our reporting segments. On a GAAP basis, we reported a loss of $1.57 per diluted share compared to earnings of $0.38 per diluted share in the prior year. On an adjusted basis, adding back product liability expense restructuring and similar items in both periods, earnings per share was $1.67, a 26% increase over the prior year. Higher operating income resulting from the higher revenues, price realization, productivity improvements and to a lesser degree, a lower tax rate contributed to the increase. Again, I want to reiterate that the change in accounting methods from LIFO to FIFO did not have an impact on the change in earnings between periods. Turning to cash flow and the balance sheet. Quarterly cash flow, excluding product liability, was $63 million. We continue to execute on a balanced capital allocation strategy. In the quarter, we invested $13 million in CapEx, paid $17 million of dividends to shareholders and repaid $16 million in debt. At the end of the year, we had cash of $141 million and net debt of $457 million or 1.6 times adjusted last 12 months EBITDA. Our strong balance sheet and cash flow provides ample capacity to invest in organic and inorganic growth opportunities. Also in the fourth quarter, as I've discussed previously, we discontinued the use of the LIFO accounting method. We believe that the FIFO method of accounting for inventory is preferable because it forms our entire inventory to a single accounting method and improves comparability against our peers. Our financial results for all the periods presented in yesterday's press release and in our Form 10-K that soon will be published, have been adjusted to reflect this accounting change. Looking back over time, LIFO had an unfavorable impact to margins in 2020 of 40 basis points and was a headwind of EPS by about $0.10. If we would have continued to report on that basis for year-end 2021, it would have had an impact of about 50 basis points for the year on margins and had been a headwind to EPS by $0.15, of which $0.09 would have been in the fourth quarter. Overall, the business is performing well. Demand is robust, and there are signs of end market improvements across the globe. We have and continue to make organic investments and evaluate other areas of growth. I've spent considerable time with customers recently and the feedback has been very positive around our products and solutions. Our market positions are healthy. Our relationships with customers and channel partners are strong, and we remain very committed and are focused on making investments to drive sustainable long-term value creation for our shareholders. We do expect supply chain and inflation headwinds to continue into 2022, especially in electronic components, and this could impact our ability to deliver products, notably in fixed gas and flame detection in the near term. As we said before, supply chain is our biggest variable. With that, the team is executing very well with our suppliers to ensure material availability and our focus on pricing has never been greater. I am proud of the work our team is doing and thank them for their unwavering commitment to our mission and our customers. With that, I'll turn the call back over to Nish for closing remarks. Nish?